Joshua T. Brumm - 01 Oct 2021 Form 4 Insider Report for Dyne Therapeutics, Inc. (DYN)

Role
Chief Executive Officer and President, Director
Signature
/s/ Richard Scalzo, Attorney-in-Fact
Issuer symbol
DYN
Transactions as of
01 Oct 2021
Net transactions value
$0
Form type
4
Filing time
04 Oct 2021, 17:03:25 UTC
Previous filing
22 Sep 2021
Next filing
14 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DYN Common Stock Gift $0 -3,500 -3.5% $0.000000 95,518 01 Oct 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was a charitable donation to a third party effective October 1, 2021 in which no value was received in return.
F2 Includes 80,270 unvested RSUs.

Remarks:

Chief Executive Officer and President